Trypanosomes in a Giemsa-stained thin blood film from a Spanish traveler returning from Tanzania.

<p>Trypanosomes in a Giemsa-stained thin blood film from a Spanish traveler returning from Tanzania.</p

Factors associated with mortality in patients with COPD and pneumonia: multivariate analysis.

<p>COPD, chronic obstructive pulmonary disease; OR: odds ratio; PSI, pneumonia severity index.</p><p>Factors associated with mortality in patients with COPD and pneumonia: multivariate analysis.</p

Factors associated with mortality in patients with COPD and pneumonia: univariate analysis.

<p>DM, diabetes mellitus; FEV1: Forced expiratory volume in the first second; ICU: Intensive care unit; IQR, interquartile range; PSI, pneumonia severity index.</p>1<p>Data available only for 52 patients and 790 patients respectively; ²Patients were stratified into the following risk classes according to the PSI score: low risk (≤90 points, classes I, II, and III) and high risk (>90 points, classes IV and V).</p><p>Factors associated with mortality in patients with COPD and pneumonia: univariate analysis.</p

Characteristics of pneumonia by study group.

<p>COPD, chronic obstructive pulmonary disease; IQR, interquartile range; PSI, pneumonia severity index.</p>1<p>Data available only for 1396 patients.²Data available from January 2001, only for 3084 patients; ³Data available from January 2001, only for 3084 patients⁴Patients were stratified into the following risk classes according to the PSI score: low risk (≤90 points, classes I, II, and III) and high risk (>90 points, classes IV and V).</p><p>Characteristics of pneumonia by study group.</p

Etiology of pneumonia by study group.

<p>COPD, chronic obstructive pulmonary disease; 72 (7.3%) patients with COPD and 118 (3.7%) patients without COPD had more than one cause of community-acquired pneumonia.</p><p>Etiology of pneumonia by study group.</p

Antibiotic therapy and outcomes of pneumonia by study group.

<p>CAP: Community-acquired pneumonia; COPD, chronic obstructive pulmonary disease; ICU: Intensive care unit; IQR, interquartile range.</p><p>Antibiotic therapy and outcomes of pneumonia by study group.</p

Characteristics of patients with COPD who had <i>Pseudomonas aeruginosa</i> pneumonia and those patients with COPD with pneumonia non-caused by <i>P. aeruginosa</i>.

<p>COPD, chronic obstructive pulmonary disease; IQR, interquartile range; PSI, pneumonia severity index.</p>1<p>Data available only for 345 patients. ²Data available for 740 patients.³Patients were stratified into the following risk classes according to the PSI score: low risk (≤90 points, classes I, II, and III) and high risk (>90 points, classes IV and V).</p><p>Characteristics of patients with COPD who had <i>Pseudomonas aeruginosa</i> pneumonia and those patients with COPD with pneumonia non-caused by <i>P. aeruginosa</i>.</p